Fortis Healthcare Ltd. share price target

The Supreme Court of India (SC) has announced its judgement in the Daiichi Sankyo-Fortis-IHH case.

Fortis Healthcare’s (FHL) Q1FY23 performance was broadly in line with our estimates. Revenues grew 5.5% YoY to Rs14.9bn (I-Sec: Rs14.5bn) with hospital segment growing 18.5% YoY.

points. FHL has a long and established track record having favourable hospital maturity mix profile with large network of healthcare facilities. It has presence across various healthcare verticals, including secondary, tertiary care and diagnostics. Fortis has operations in India, United Arab Emirates (UAE) & Sri Lanka. With its...

Large hospital chain at a significant discount to market leader Apollo Hospitals

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise of hospitals, diagnostics and day care specialty facilities. Currently, the company...

Fortis Healthcare (FORH) reported 2QFY18/3QFY18 revenue of INR12b (flat YoY)/INR11.2b (-1.1% YoY), with EBIDTA margin of 8.9%/4.6%. Hospital business revenue came in at INR9.7b (-0.6% YoY)/INR9b (-0.9% YoY) for2QFY18/3QFY18, with EBITDA margin of 8.5%/5.5%. SRL reported revenue ofINR2.2b (+5.2% YoY)/INR2.1b (+10% YoY), with EBITDA margin of 23.2%/18.4%.2Q numbers were in line, but 3Q numbers missed our expectations. FORH reported a loss of INR236m/INR191m in 2Q/3QFY18.

...